Alzheimer's disease pathogenesis and the desynchronization of cortico-limbic circadian rhythms
阿尔茨海默病的发病机制和皮质边缘昼夜节律的不同步
基本信息
- 批准号:10612391
- 负责人:
- 金额:$ 71.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AffectAlzheimer like pathologyAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAmyloid beta-ProteinAnimalsBasic ScienceBehavioralBrainBrain regionCREB1 geneCause of DeathCell Culture TechniquesCellsCephalicCircadian DysregulationCircadian RhythmsClinicalClinical ResearchCognitionCognitive deficitsComplementComplexConfocal MicroscopyDataDendritic SpinesDiseaseDisease ProgressionElderlyFunctional disorderGene ExpressionGenerationsGenesGeneticGoalsHippocampusHourImageImmunofluorescence ImmunologicIndividualInterventionLearningMAP Kinase GeneModelingMolecularMultiphoton Fluorescence MicroscopyMusNeurodegenerative DisordersNeuronsPathogenesisPathologyPathway interactionsPersonsPhasePopulationProsencephalonReporterReporter GenesRoleSeriesSignal PathwaySignal TransductionSliceStructureSynaptic plasticitySystemTestingTransgenic MiceTransgenic OrganismsVenusWorkabeta oligomeramyloidogenesiscircadiancircadian pacemakercortico-limbic circuitsdesignexperimental studyfrontal lobefunctional plasticityimaging modalityin vivoinnovationmouse modelmultiphoton microscopyneuralnovel therapeutic interventionoverexpressionresearch studysuprachiasmatic nucleustranscriptomic profiling
项目摘要
Recent work has established a clear connection between Alzheimer’s disease (AD) and the disruption of the
circadian timing system. However, the mechanistic underpinnings of this relationship have not been clearly
identified. Interestingly, if we attempt to deconstruct this relationship and place it within the context of the
profound effects that Alzheimer’s disease has on cognition, several ideas begin to come into focus. First, data
to date has revealed that circadian timing within cortico-limbic circuits modulates complex behavioral states,
including cognition. Second, AD has marked effects on functional plasticity of these same circuits. These
observations raise an interesting question: could the cognitive deficits in AD result, in part, from the
dysregulation of circadian timing within cortico-limbic circuits? As an initial examination of this idea, we
propose to test the following hypothesis: The cognitive deficits during early- to mid-stage of AD results in part from
a systems-wide breakdown in the fidelity of the cortico-limbic circadian timing systems. To test this hypothesis, we
have assembled an innovative set of transgenic mouse models and state-of-the-art imaging methods that will
allow us to both profile and manipulate circadian timing over the course of disease progression. In Aim 1, the
effects of amyloid β peptide (Aβ) on the fidelity of cellular-and circuit-based time-keeping capacity will be
examined. In Exp. 1A, we will use a cell-culture based profiling approach to test the effects of Aβ oligomer on
the cell autonomous circadian timekeeping capacity of neurons isolated from the SCN (the locus of the master
circadian clock), the cortex and the hippocampus. In Exp. 1B brain slice explant imaging will be used to test
the effects of Aβ on circuit-based circadian rhythm generation. In Aim 2 we propose to profile clock timing and
clock-gated gene expression in the 5XFAD mouse model of AD. In Exp. 2A, cranial window imaging (via
multiphoton microscopy) of clock timing in the frontal cortex and the hippocampus will be used to generate a
cellular- and systems-level profile of clock phasing, rhythm amplitude and oscillator synchrony over the
course of the AD-like pathology. This study will be complemented by immunofluorescence-based clock gene
profiling (Exp. 2B) and by transcriptomic profiling (Exp. 2C). In Aim 3, we will test the effects that disease
progression in the 5XFAD model has on clock-gated (Exp. 3A) and activity-evoked (Exp. 3B) cellular signaling,
as well as on dendritic spine formation. In Aim 4 we will test whether the desynchronization of cortico-limbic
oscillators underlies the cognitive deficits in the 5XFAD mouse model of AD. Key to this aim will be to test
whether the clock enhancing compound PF-670462 triggers the resynchronization of cortico-limbic oscillator
populations, and if so, whether this effect underlies the capacity of PF-670462 to augment cognition. If our
underlying hypothesis is validated, these data will provide an important starting point for new lines of inquiry
(and potentially new therapeutic interventions) designed to further understand the mechanistic relationships
(at a cellular, systems, and genetics level) between circadian timing and AD pathogenesis.
最近的研究已经确立了阿尔茨海默病(AD)与大脑中神经系统紊乱之间的明确联系
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ribosomal S6 Kinase Regulates the Timing and Entrainment of the Mammalian Circadian Clock Located in the Suprachiasmatic Nucleus.
核糖体 S6 激酶调节位于视交叉上核的哺乳动物昼夜节律时钟的时间和夹带。
- DOI:10.1016/j.neuroscience.2023.02.003
- 发表时间:2023
- 期刊:
- 影响因子:3.3
- 作者:Hoyt,KariR;Li,Aiqing;Yoon,Hyojung;Weisenseel,Zachary;Watkins,Jacob;Fischer,Alex;Obrietan,Karl
- 通讯作者:Obrietan,Karl
Light-induced changes in the suprachiasmatic nucleus transcriptome regulated by the ERK/MAPK pathway.
- DOI:10.1371/journal.pone.0249430
- 发表时间:2021
- 期刊:
- 影响因子:3.7
- 作者:Alzate-Correa D;Aten S;Campbell MJ;Hoyt KR;Obrietan K
- 通讯作者:Obrietan K
SynGAP is expressed in the murine suprachiasmatic nucleus and regulates circadian-gated locomotor activity and light-entrainment capacity.
- DOI:10.1111/ejn.15043
- 发表时间:2021-03
- 期刊:
- 影响因子:0
- 作者:Aten S;Kalidindi A;Yoon H;Rumbaugh G;Hoyt KR;Obrietan K
- 通讯作者:Obrietan K
Circadian clocks, cognition, and Alzheimer's disease: synaptic mechanisms, signaling effectors, and chronotherapeutics.
- DOI:10.1186/s13024-022-00537-9
- 发表时间:2022-05-07
- 期刊:
- 影响因子:15.1
- 作者:Hoyt, Kari R.;Obrietan, Karl
- 通讯作者:Obrietan, Karl
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KARI RENE HOYT其他文献
KARI RENE HOYT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KARI RENE HOYT', 18)}}的其他基金
MAPK signaling: gates, oscillators and circadian timing
MAPK 信号:门、振荡器和昼夜节律计时
- 批准号:
10596087 - 财政年份:2020
- 资助金额:
$ 71.98万 - 项目类别:
Alzheimer's disease pathogenesis and the desynchronization of cortico-limbic circadian rhythms
阿尔茨海默病的发病机制和皮质边缘昼夜节律的不同步
- 批准号:
10221593 - 财政年份:2020
- 资助金额:
$ 71.98万 - 项目类别:
MAPK signaling: gates, oscillators and circadian timing
MAPK 信号:门、振荡器和昼夜节律计时
- 批准号:
10133091 - 财政年份:2020
- 资助金额:
$ 71.98万 - 项目类别:
Alzheimer's disease pathogenesis and the desynchronization of cortico-limbic circadian rhythms
阿尔茨海默病的发病机制和皮质边缘昼夜节律的不同步
- 批准号:
10398203 - 财政年份:2020
- 资助金额:
$ 71.98万 - 项目类别:
MAPK signaling: gates, oscillators and circadian timing
MAPK 信号:门、振荡器和昼夜节律计时
- 批准号:
9981221 - 财政年份:2020
- 资助金额:
$ 71.98万 - 项目类别:
MAPK signaling: gates, oscillators and circadian timing
MAPK 信号:门、振荡器和昼夜节律计时
- 批准号:
10375498 - 财政年份:2020
- 资助金额:
$ 71.98万 - 项目类别:
Alzheimer's disease pathogenesis and the desynchronization of cortico-limbic circadian rhythms
阿尔茨海默病的发病机制和皮质边缘昼夜节律的不同步
- 批准号:
10053947 - 财政年份:2020
- 资助金额:
$ 71.98万 - 项目类别:
Therapeutic potential of ARE-mediated gene expression in Huntington's disease
ARE 介导的基因表达在亨廷顿病中的治疗潜力
- 批准号:
7981119 - 财政年份:2010
- 资助金额:
$ 71.98万 - 项目类别:
Excitotoxic Signaling in HD Transgenic Neurons
HD 转基因神经元中的兴奋毒性信号传导
- 批准号:
6685929 - 财政年份:2001
- 资助金额:
$ 71.98万 - 项目类别:
Excitotoxic Signaling in HD Transgenic Neurons
HD 转基因神经元中的兴奋毒性信号传导
- 批准号:
6434523 - 财政年份:2001
- 资助金额:
$ 71.98万 - 项目类别:
相似海外基金
HUCBC modulation of Alzheimer-like pathology and behavioral changes
HUCBC 调节阿尔茨海默样病理和行为变化
- 批准号:
7391934 - 财政年份:2007
- 资助金额:
$ 71.98万 - 项目类别:
ALZHEIMER LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
包涵体肌病中的阿尔茨海默病样病理学
- 批准号:
6448889 - 财政年份:2001
- 资助金额:
$ 71.98万 - 项目类别:
ALZHEIMER LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
包涵体肌病中的阿尔茨海默病样病理学
- 批准号:
6353435 - 财政年份:2000
- 资助金额:
$ 71.98万 - 项目类别:
ALZHEIMER LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
包涵体肌病中的阿尔茨海默病样病理学
- 批准号:
6318249 - 财政年份:2000
- 资助金额:
$ 71.98万 - 项目类别:
ALZHEIMER LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
包涵体肌病中的阿尔茨海默病样病理学
- 批准号:
6295391 - 财政年份:1999
- 资助金额:
$ 71.98万 - 项目类别:
ALZHEIMER-LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
包涵体肌病中的阿尔茨海默病样病理学
- 批准号:
2837339 - 财政年份:1999
- 资助金额:
$ 71.98万 - 项目类别:
ALZHEIMER-LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
包涵体肌病中的阿尔茨海默病样病理学
- 批准号:
6948644 - 财政年份:1999
- 资助金额:
$ 71.98万 - 项目类别:
ALZHEIMER-LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
包涵体肌病中的阿尔茨海默病样病理学
- 批准号:
6884632 - 财政年份:1999
- 资助金额:
$ 71.98万 - 项目类别:
ALZHEIMER LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
包涵体肌病中的阿尔茨海默病样病理学
- 批准号:
6098054 - 财政年份:1999
- 资助金额:
$ 71.98万 - 项目类别:
ALZHEIMER-LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
包涵体肌病中的阿尔茨海默病样病理学
- 批准号:
6509651 - 财政年份:1999
- 资助金额:
$ 71.98万 - 项目类别: